FDA perspective: enrolment of elderly transplant recipients in clinical trials.
about
Immunosenescence and immune response in organ transplantation.Results of a Community Randomized Study of a Faith-Based Education Program to Improve Clinical Trial Participation among African AmericansInduction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study.
P2860
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@en
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@nl
type
label
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@en
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@nl
prefLabel
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@en
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@nl
P2093
P1433
P1476
FDA perspective: enrolment of elderly transplant recipients in clinical trials.
@en
P2093
Joette M Meyer
Patrick Archdeacon
Renata Albrecht
P304
P356
10.1097/TP.0B013E31828279D9
P577
2013-04-01T00:00:00Z